TO0: (4S)-4-[2-(2-{4-[(2E)-4-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}-4-oxobut-2-en-1-yl]piperazin-1-yl}ethoxy)acetamido]-1-{(2S)-2-cyclohexyl-2-[(N-methyl-L-alanyl)amino]acetyl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-L-prolinamide unbound form
TO0 is a Ligand Of Interest in 8DSF designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8DSF_TO0_A_402 | 83% | 68% | 0.058 | 0.954 | 0.24 | 0.81 | - | 2 | 0 | 0 | 100% | 1 |
| 8DSF_TO0_B_402 | 82% | 66% | 0.058 | 0.952 | 0.27 | 0.85 | - | 3 | 0 | 0 | 100% | 1 |
| 8DSF_TO0_D_402 | 13% | 66% | 0.126 | 0.831 | 0.26 | 0.86 | - | 2 | 0 | 0 | 47% | 1 |
| 8DSF_TO0_C_402 | 9% | 63% | 0.141 | 0.805 | 0.21 | 1.01 | - | 2 | 0 | 0 | 47% | 1 |














